COPD & COVID-19.
作者信息
Halpin David M G, Vogelmeier Claus F, Agusti Alvar A
机构信息
University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany.
出版信息
Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):162-164. doi: 10.1016/j.arbr.2021.01.004. Epub 2021 Mar 10.
Abstract
摘要
相似文献
1
COPD & COVID-19.慢性阻塞性肺疾病与2019冠状病毒病
Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):162-164. doi: 10.1016/j.arbr.2021.01.004. Epub 2021 Mar 10.
2
Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.生物信息学和系统生物学方法鉴定 SARS-CoV-2 感染对特发性肺纤维化和慢性阻塞性肺疾病患者的影响。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab115.
3
Chronic obstructive pulmonary disease and COVID-19: interrelationships.慢性阻塞性肺疾病与 COVID-19：相互关系。
Curr Opin Pulm Med. 2022 Mar 1;28(2):76-83. doi: 10.1097/MCP.0000000000000834.
4
Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.肺空间分析揭示 COVID-19 致死患者 COPD 患者中的 T 细胞特征。
Cells. 2022 Jun 7;11(12):1864. doi: 10.3390/cells11121864.
5
Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.哮喘、COPD 和 SARS-CoV-2 感染（COVID-19）：潜在的机制见解。
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.00920-2021. Print 2021 Aug.
6
COVID-19 and 'basal' exacerbation frequency in COPD.COVID-19与慢性阻塞性肺疾病（COPD）的“基础”加重频率
Thorax. 2021 May;76(5):432-433. doi: 10.1136/thoraxjnl-2020-216637. Epub 2020 Dec 22.
7
Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.吸烟人群和 COPD 患者小气道中内吞作用机制和 ACE2 的失调会增加其对 SARS-CoV-2（COVID-19）感染的易感性。
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L158-L163. doi: 10.1152/ajplung.00437.2020. Epub 2020 Nov 11.
8
Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.外周肺 club 细胞中的血管紧张素转换酶 2 调节慢性阻塞性肺疾病对 SARS-CoV-2 的易感性。
Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L712-L721. doi: 10.1152/ajplung.00305.2021. Epub 2022 Mar 23.
9
Management of patients with chronic obstructive pulmonary disease (COPD) during COVID-19.COVID-19 期间慢性阻塞性肺疾病（COPD）患者的管理。
Pol Merkur Lekarski. 2022 Aug 23;50(298):262-263.
10
Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.慢性阻塞性肺疾病和结核病患者中 COVID-19 的患病率。
Ann Med. 2023 Dec;55(1):285-291. doi: 10.1080/07853890.2022.2160491.
引用本文的文献
1
High Flow Nasal Cannula Versus Noninvasive Positive Pressure Ventilation as Initial Respiratory Support in Patients with Chronic Obstructive Pulmonary Disease and Covid-19: Exploratory Analysis in Two Intensive Care Units.高流量鼻导管与无创正压通气在慢性阻塞性肺疾病合并新冠病毒感染患者初始呼吸支持中的比较：两个重症监护病房的探索性分析。
Acta Med Acad. 2022 Dec;51(3):199-208. doi: 10.5644/ama2006-124.389. Epub 2022 Dec 15.
2
The Psychosocial Impact of the COVID-19 Pandemic on Chronic Care Patients.新冠肺炎疫情对慢性病患者的心理社会影响。
J Am Med Dir Assoc. 2023 Apr;24(4):426-433.e2. doi: 10.1016/j.jamda.2023.01.003. Epub 2023 Jan 16.
3
Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome.病例报告：偶然发现嗜铬细胞瘤是长新冠综合征的病因。
Front Endocrinol (Lausanne). 2022 Sep 27;13:967995. doi: 10.3389/fendo.2022.967995. eCollection 2022.
4
Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒大流行对支气管扩张症患者的影响：一项多中心研究。
Antibiotics (Basel). 2022 Aug 12;11(8):1096. doi: 10.3390/antibiotics11081096.
5
Chronic obstructive pulmonary disease patients' quality of life and its related factors: A cross-sectional study of the Jordanian population.慢性阻塞性肺疾病患者的生活质量及其相关因素：约旦人群的横断面研究。
F1000Res. 2022 May 26;11:581. doi: 10.12688/f1000research.121783.1. eCollection 2022.
6
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.COVID-19 感染对既往呼吸道疾病的短期和长期影响。
Arch Bronconeumol. 2022 Apr;58 Suppl 1:39-50. doi: 10.1016/j.arbres.2022.03.011. Epub 2022 Apr 15.
7
Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.患病肺部可能阻碍 COVID-19 发展：COVID-19 患者中 COPD 患病率较低的一个可能原因。
Med Hypotheses. 2021 Aug;153:110628. doi: 10.1016/j.mehy.2021.110628. Epub 2021 Jun 9.
8
Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease.新型冠状病毒在慢性阻塞性肺疾病患者肺组织中的分子相互作用
Ann Am Thorac Soc. 2021 Nov;18(11):1922-1924. doi: 10.1513/AnnalsATS.202006-619RL.
本文引用的文献
1
COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study.与长期呼吸系统疾病患者相关的 COVID-19 担忧：一项定性研究。
BMC Pulm Med. 2020 Dec 9;20(1):319. doi: 10.1186/s12890-020-01363-9.
2
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.新型冠状病毒肺炎与慢性阻塞性肺疾病：基础科学与临床结局的叙述性综述。
Eur Respir Rev. 2020 Nov 5;29(158). doi: 10.1183/16000617.0199-2020. Print 2020 Dec 31.
3
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
4
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.新型冠状病毒肺炎患者的凝血病、静脉血栓栓塞和抗凝治疗。
Pharmacotherapy. 2020 Nov;40(11):1130-1151. doi: 10.1002/phar.2465. Epub 2020 Nov 3.
5
Effect of Face Masks on Gas Exchange in Healthy Persons and Patients with Chronic Obstructive Pulmonary Disease.口罩对健康人和慢性阻塞性肺疾病患者气体交换的影响。
Ann Am Thorac Soc. 2021 Mar;18(3):541-544. doi: 10.1513/AnnalsATS.202007-812RL.
6
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.在使用 OpenSAFELY 平台的观察性队列研究中，接受吸入皮质类固醇治疗的慢性阻塞性肺疾病或哮喘患者发生 COVID-19 相关死亡的风险。
Lancet Respir Med. 2020 Nov;8(11):1106-1120. doi: 10.1016/S2213-2600(20)30415-X. Epub 2020 Sep 24.
7
Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?吸入性糖皮质激素与新冠病毒疾病相关死亡率：是混淆因素还是明确因素？
Lancet Respir Med. 2020 Nov;8(11):1065-1066. doi: 10.1016/S2213-2600(20)30447-1. Epub 2020 Sep 24.
8
COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force.2019冠状病毒病：欧洲呼吸学会和美国胸科学会联合协调的国际特别工作组发布的关于医院及出院后康复的临时指南
Eur Respir J. 2020 Dec 3;56(6). doi: 10.1183/13993003.02197-2020. Print 2020 Dec.
9
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.新冠重症患者的合并感染与抗生素管理：一项前瞻性队列分析
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
10
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?COVID-19 相关的急性呼吸窘迫综合征：是否需要采取不同的治疗方法？
Lancet Respir Med. 2020 Aug;8(8):816-821. doi: 10.1016/S2213-2600(20)30304-0. Epub 2020 Jul 6.
Zotero 插件